This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Noxxon Pharma Ag. Active years: 2011.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2011
Title: Sandra Stark: Innovator in Nucleic Acid Technology
Introduction
Sandra Stark is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of biotechnology, particularly in the development of nucleic acid technologies. Her innovative work has led to the creation of a patent that addresses critical health issues.
Latest Patents
Sandra Stark holds a patent for "CGRP binding nucleic acids." This invention relates to an antagonist for CGRP and amylin, where the antagonist is a nucleic acid that binds to CGRP or amylin. The nucleic acid preferably comprises an L-nucleotide, showcasing her expertise in molecular biology and therapeutic applications.
Career Highlights
Sandra is currently associated with Noxxon Pharma AG, a company focused on developing innovative therapies. Her role at Noxxon Pharma AG allows her to apply her knowledge and skills in a practical setting, contributing to advancements in medical science.
Collaborations
Some of her notable coworkers include Mathias Bell and Axel Vater. Their collaboration enhances the research environment and fosters innovation within the company.
Conclusion
Sandra Stark's contributions to nucleic acid technology exemplify her dedication to advancing medical science. Her innovative patent and work at Noxxon Pharma AG highlight her role as a leading inventor in her field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile